My HPRA: Register

FAMVIR

250 Milligram Film Coated Tablet

PCO ManufacturingPPA0465/212/001

SPC: DATE OF REVISION OF THE TEXT

18 May 2015 - 26 Aug 2015	26 Aug 2015 - 12 Jul 2016
July 2014	August 2015

« Back

Follow medicine

Print

Latest Changes to Medicine Info & SPC

12 Jul 2016
SPC: DATE OF REVISION OF THE TEXT
12 Jul 2016
SPC: Shelf life
26 Aug 2015
SPC: DATE OF REVISION OF THE TEXT
26 Aug 2015
SPC: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
26 Aug 2015
SPC: PARALLEL PRODUCT AUTHORISATION HOLDER
26 Aug 2015
SPC: Shelf life
26 Aug 2015
SPC: Preclinical safety data
26 Aug 2015
SPC: Pharmacokinetic properties
26 Aug 2015
SPC: Pharmacodynamic properties
26 Aug 2015
SPC: PHARMACOLOGICAL PROPERTIES
26 Aug 2015
SPC: Overdose
26 Aug 2015
SPC: Undesirable effects
26 Aug 2015
SPC: Effects on ability to drive and use machines
26 Aug 2015
SPC: Fertility, pregnancy and lactation
26 Aug 2015
SPC: Interaction with other medicinal products and other forms of interaction
26 Aug 2015
SPC: Special warnings and precautions for use
26 Aug 2015
SPC: Contraindications
26 Aug 2015
SPC: Posology and method of administration
26 Aug 2015
SPC: Therapeutic Indications
26 Aug 2015
SPC: CLINICAL PARTICULARS
26 Aug 2015
SPC: PHARMACEUTICAL FORM
26 Aug 2015
SPC: QUALITATIVE AND QUANTITATIVE COMPOSITION

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.

Important information regarding cookies and the HPRA

By using this website, you consent to the use of cookies in accordance with the HPRA Cookie Policy.
For more information on cookies, see our cookie policy.

Click here to accept the cookie policy and hide this message